DE602005018172D1 - Medizinische lösung; verfahren zur herstellung dieser lösung und ihre verwendung - Google Patents

Medizinische lösung; verfahren zur herstellung dieser lösung und ihre verwendung

Info

Publication number
DE602005018172D1
DE602005018172D1 DE602005018172T DE602005018172T DE602005018172D1 DE 602005018172 D1 DE602005018172 D1 DE 602005018172D1 DE 602005018172 T DE602005018172 T DE 602005018172T DE 602005018172 T DE602005018172 T DE 602005018172T DE 602005018172 D1 DE602005018172 D1 DE 602005018172D1
Authority
DE
Germany
Prior art keywords
solution
medical
medical solution
preparing
carbon dioxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005018172T
Other languages
English (en)
Inventor
Malin Ernebrant
Gert-Inge Bertinsson
Torbjoern Linden
Lars-Fride Olsson
Theodor Sandstroem
Therese Svensson
Anders Wieslander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gambro Lundia AB
Original Assignee
Gambro Lundia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gambro Lundia AB filed Critical Gambro Lundia AB
Publication of DE602005018172D1 publication Critical patent/DE602005018172D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602005018172T 2004-03-01 2005-02-22 Medizinische lösung; verfahren zur herstellung dieser lösung und ihre verwendung Active DE602005018172D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54921504P 2004-03-01 2004-03-01
SE0400523A SE0400523D0 (sv) 2004-03-01 2004-03-01 A medical solution, a method for producing said medical solution and use thereof
PCT/SE2005/000278 WO2005082383A1 (en) 2004-03-01 2005-02-22 A medical solution, a method for producing said medical solution and use thereof

Publications (1)

Publication Number Publication Date
DE602005018172D1 true DE602005018172D1 (de) 2010-01-21

Family

ID=32067298

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005018172T Active DE602005018172D1 (de) 2004-03-01 2005-02-22 Medizinische lösung; verfahren zur herstellung dieser lösung und ihre verwendung

Country Status (12)

Country Link
US (1) US9161980B2 (de)
EP (1) EP1722802B1 (de)
JP (2) JP5762665B2 (de)
KR (1) KR101236663B1 (de)
CN (1) CN1905889A (de)
AT (1) ATE451109T1 (de)
AU (1) AU2005216846B2 (de)
CA (1) CA2548771C (de)
DE (1) DE602005018172D1 (de)
ES (1) ES2336802T3 (de)
SE (1) SE0400523D0 (de)
WO (1) WO2005082383A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0402507D0 (sv) 2004-10-14 2004-10-14 Gambro Lundia Ab Medicinsk lösning, förfarande för framställning och användning därav
US9585810B2 (en) 2010-10-14 2017-03-07 Fresenius Medical Care Holdings, Inc. Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser
US20120199205A1 (en) 2011-02-03 2012-08-09 Fresenius Medical Care Deutschland Gmbh System for preparing a medical fluid and method for preparing a medical fluid
JP6356943B2 (ja) * 2012-10-22 2018-07-11 出光興産株式会社 （メタ）アクリレート系組成物、硬化物、及びこれを封止材とする光半導体装置
US11925703B1 (en) 2022-07-29 2024-03-12 Xellia Pharmaceuticals Aps Liquid composition comprising glucose

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970750A (en) 1974-10-08 1976-07-20 Sandoz, Inc. Effervescent potassium chloride composition
US3993750A (en) 1974-12-20 1976-11-23 Research Corporation Aqueous hypertonic solution and compositions useful for preparation of same
JPS5791912A (en) 1980-11-25 1982-06-08 Kyosei Seiyaku Kk Concentrated electrolyte solution for intravenous nutrition transfusion
WO1983000293A1 (en) 1981-07-21 1983-02-03 Univ Leland Stanford Junior Stable supersaturated solutions of sparingly soluble salts
US4548817A (en) 1984-01-20 1985-10-22 Webb-Waring Lung Institute Composition and method for treating mammalian acidosis
IT1214872B (it) 1984-04-06 1990-01-18 Mariano Feriani Sacca contenente due o piu'sostanze per infusione ad uso medicale, poste in scomparti separati, comprendente mezzi atti a consentire la miscelazione di tali sostanze solo al momento dell'uso.
ATE82500T1 (de) 1984-06-22 1992-12-15 Richard L Veech Elektrolytloesungen und deren (in vivo) verwendung.
DE3917251A1 (de) 1989-05-26 1990-11-29 Fresenius Ag Natriumbicarbonat enthaltendes konzentrat sowie verfahren zur herstellung einer dialysierfluessigkeit
ES2056497T3 (es) 1990-01-12 1994-10-01 Nephro Medica Pharma Solucion para infusion y dialisis que contiene bicarbonato y calcio.
DE4125819A1 (de) * 1991-08-03 1993-02-04 Rolf Prof Dr Med Zander Waessrige loesung und deren verwendung
US5261872A (en) 1992-05-01 1993-11-16 Goldenberg Zana S Ingrown toenail correction appliance
US6156007A (en) 1992-09-04 2000-12-05 Hemotherm, Inc. Apparatus for whole-body hyperthermia
CA2129509A1 (en) 1993-09-10 1995-03-11 Kazumi Ogata Pharmaceutical composition for renal disorder and a dialysis solution for extracorporeal hemodialysis
JP3623294B2 (ja) 1995-11-28 2005-02-23 株式会社新素材総合研究所 電解質液が収容された医療用容器及びその製造方法
US6017942A (en) 1996-10-31 2000-01-25 Baxter International Inc. Method and compositions for the treatment of renal failure
CA2276442C (en) 1996-12-31 2012-01-17 Ajay Gupta Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients
DE19748290B8 (de) 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
JP2000016484A (ja) * 1998-04-30 2000-01-18 Hiroshi Motobayashi 炭酸成分溶液を収容したプラスチック容器及びその製造方法
AU4553700A (en) 1999-04-26 2000-11-10 Pe Chou Chang Substitution infusion fluid and citrate anticoagulation
WO2001000204A1 (en) 1999-06-30 2001-01-04 Ajay Gupta Method and pharmaceutical composition for parenteral administration of iron
US6309673B1 (en) 1999-09-10 2001-10-30 Baxter International Inc. Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
SE0001939D0 (sv) * 2000-05-25 2000-05-25 Gambro Lundia Ab Medical solution and use thereof
ITMI20020516A1 (it) 2002-03-12 2003-09-12 Gambro Lundia Ab Liquidi per dialisi peritoneale emodialisi e reintegrazione
SE0402507D0 (sv) * 2004-10-14 2004-10-14 Gambro Lundia Ab Medicinsk lösning, förfarande för framställning och användning därav

Also Published As

Publication number Publication date
ES2336802T3 (es) 2010-04-16
WO2005082383A1 (en) 2005-09-09
EP1722802A1 (de) 2006-11-22
KR101236663B1 (ko) 2013-02-22
KR20060129424A (ko) 2006-12-15
US9161980B2 (en) 2015-10-20
JP5908352B2 (ja) 2016-04-26
US20070298125A1 (en) 2007-12-27
EP1722802B1 (de) 2009-12-09
CA2548771A1 (en) 2005-09-09
AU2005216846A1 (en) 2005-09-09
ATE451109T1 (de) 2009-12-15
JP2007525537A (ja) 2007-09-06
SE0400523D0 (sv) 2004-03-01
CN1905889A (zh) 2007-01-31
JP2012232986A (ja) 2012-11-29
CA2548771C (en) 2014-01-14
JP5762665B2 (ja) 2015-08-12
AU2005216846B2 (en) 2010-03-04

Similar Documents

Publication Publication Date Title
IS8870A (is) Lyfjablanda sem felur í sér andrógen
DE69632709D1 (de) Methode für die herstellung und lagerung von lösungen
DE602005018172D1 (de) Medizinische lösung; verfahren zur herstellung dieser lösung und ihre verwendung
WO2007025280A3 (en) Electrochemical cell for the production of synthesis gas using atmospheric air and water
DE50310614D1 (de) Verfahren zur herstellung von c13-alkoholgemischen
ATE321056T1 (de) Verfahren zur herstellung von mercaptoalkylalkoxysilanen
ATE426586T1 (de) Verfahren zur herstellung von cyclohexanon und cyclohexanol
DE59810718D1 (de) Verfahren zur herstellung von reinem guarkernmehl
ATE426403T1 (de) Photosensibilisator und verfahren zu seiner herstellung
DE50113004D1 (de) Verfahren zur herstellung von salpetersäure
DE60312033D1 (de) Verfahren zur verringerung der bitterkeit von aminosäure
KR100387340B1 (en) Weak alkaline organic fertilizer using organic waste such as food garbages and preparation thereof
ATE264129T1 (de) Methode zur herstellung einer flüssigen mischung
DE602006003769D1 (de) Verfahren zur herstellung von 4-amino-4'-demethyl-4-desoxypodophylotoxin
ATE476426T1 (de) Verfahren zur herstellung von alkoxycarbonylamino-triazinen
ATE324937T1 (de) Verfahren und anlage zur dynamischen behandlung von gas, insbesondere für medizinische zwecke
ATE271533T1 (de) Verfahren zur herstellung von alkincarbonsäuren durch oxidation von alkinalkoholen
ATE335750T1 (de) Verfahren zur herstellung von organosilylalkylpolysulfanen
DE50009362D1 (de) Verfahren zur Herstellung eines funktionalen hochenergetischen Materials
ATE358507T1 (de) Herstellung von dialysekonzentrat aus einer hochverdichteten konzentratvorstufe und vorrichtung zur anwendung am dialyseplatz.
DE60037876D1 (de) Verfahren zur Herstellung von entwickelten und unentwickelten Pankreasendokrinezellen, Zellpräparat und Verwendung davon zur Behandlung von Diabetes
DE60223510D1 (de) Landwirtschaftliche und gartenbauliche zusammensetzung
DE50300240D1 (de) Verfahren und Vorrichtung zur Bereitstellung von Atemgas
ATE317259T1 (de) Verfahren zur herstellung fester formulierungen von natrium-3-hydroxy-3-methylbutyrat
ATE438301T1 (de) Technik zur behandlung von mumien

Legal Events

Date Code Title Description
8364 No opposition during term of opposition